Incyte (INCY) Common Equity (2010 - 2026)
Incyte (INCY) posted Common Equity of $5.6 billion for Q1 2026, up 8.81% on a QoQ basis from $5.2 billion in Q4 2025, and up 53.31% year-over-year from $3.7 billion in Q1 2025.
Incyte (INCY) Common Equity (2010 - 2026) Analysis & Trends
Incyte's Common Equity history runs 17 years deep, the most recent figure standing at $5.6 billion for Q1 2026.
- Quarterly Common Equity rose 53.31% year-over-year to $5.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 billion (up 53.31% YoY) and the FY2025 annual result came in at $5.2 billion, up 49.89% from the prior year.
- Common Equity was $5.6 billion for Q1 2026 at Incyte, up from $5.2 billion in the prior quarter.
- Across five years, Common Equity topped out at $5.6 billion in Q1 2026 and bottomed at $3.0 billion in Q2 2024.
- A 5-year average of $4.4 billion and a median of $4.4 billion in 2022 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2024 — Common Equity sank 36.78% — and 2026, when it surged 53.31%.
- Incyte's Common Equity stood at $4.4 billion in 2022, then advanced by 18.76% to $5.2 billion in 2023, then tumbled by 33.57% to $3.4 billion in 2024, then jumped by 49.89% to $5.2 billion in 2025, then increased by 8.81% to $5.6 billion in 2026.
- Business Quant data shows INCY's Common Equity at $5.6 billion in Q1 2026, $5.2 billion in Q4 2025, and $4.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | 5.62 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.62 Bn |
| Dec 31, 2025 | 5.17 Bn |
| Sep 30, 2025 | 4.65 Bn |
| Jun 30, 2025 | 4.17 Bn |
| Mar 31, 2025 | 3.67 Bn |
| Dec 31, 2024 | 3.45 Bn |
| Sep 30, 2024 | 3.17 Bn |
| Jun 30, 2024 | 3.00 Bn |
| Mar 31, 2024 | 5.39 Bn |
| Dec 31, 2023 | 5.19 Bn |
| Sep 30, 2023 | 4.93 Bn |
| Jun 30, 2023 | 4.74 Bn |
| Mar 31, 2023 | 4.46 Bn |
| Dec 31, 2022 | 4.37 Bn |
| Sep 30, 2022 | 4.23 Bn |
| Jun 30, 2022 | 4.09 Bn |
| Mar 31, 2022 | 3.86 Bn |
| Dec 31, 2021 | 3.77 Bn |
| Sep 30, 2021 | 3.15 Bn |
| Jun 30, 2021 | 2.94 Bn |